Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

BlackBerry Ltd (BBRY), Oasis Petroleum Inc. (OAS), Rosetta Resources Inc. (ROSE): Trishield Capital’s Top Small-Cap Picks

Page 1 of 2

Jeff Buick‘s Trishield Capital Management recently submitted its 13F filing with the U.S. Securities and Exchange Commission for the quarterly period ended March 31. The filing indicated that the fund had $112.71 million worth of holdings in its public equity portfolio value, an uptick of $36.98 million from the previous filing period. The Manhattan, New York-based hedge fund had $207 million in assets under management. Trishield Capital Management mainly focuses on distressed, special, and event-driven investment opportunities. Based on the hedge fund’s investment strategy, Insider Monkey has been keenly following its activities and in this article we’ll unveil the fund’s top three small-cap picks heading into the second quarter. The three companies in question are Oasis Petroleum Inc. (NYSE:OAS), BlackBerry Ltd (NASDAQ:BBRY), and Rosetta Resources Inc. (NASDAQ:ROSE).

BlackBerry Ltd (NASDAQ:BBRY), BlackBerry corner, fuorisalone, people, black, editorial, mobile, design,

Adriano Castelli /

Before looking into these three stocks, it’s important to shed a little light on why more investors are including small-cap picks in their investment portfolios and why we are encouraging investors to do so, when done properly. According to our research into the performance of the 15 most popular small-cap picks of hedge funds between 1999 and 2012, it became apparent that these stocks outdo the S&P 500 Total Return Index, having done so by one percentage point per month on average over the course of that period. We launched our flagship small-cap strategy in August 2012 based on this compelling research and it has not disappointed us or its investors since, returning over 142% since then and blasting the market by more than 84 percentage points (more details here).

As of the most recent 13F reporting period, Trishield Capital Management holds a total of 553,586 shares of Oasis Petroleum Inc. (NYSE:OAS), with a market value of $7.87 million. The dynamics in the energy sector have seen the stock generate widespread interest, including from Trishield, for whom the stock was a new pick. Wall Street analysts have given the stock a consensus rating of 2.21, meaning the stock ranks as a solid “Buy” candidate. The company posted $0.28 in earnings per share in its most recent earnings report, beating estimates by $0.01. However, the company recorded revenue of $180.40 million, well short of analysts’ expectations of $262.10 million. Compared to the corresponding quarter last year, the revenue represented a steep decline of 44%. TheStreet Ratings recently gave the stock a “hold” rating, citing a number of factors, some of which show strengths while others show weaknesses. Strengths include expanding profit margins and healthy valuation status while the negative traits are worsening net income, weaker cash flow, and poor return-on-equity. During the quarter, a number of hedge funds had interest in the stock, including John Scully‘s SPO Advisory Corp, which held a total of 20.37 million shares of the firm, having upped its position from 7.73 million. A few others are billionaire John Paulson’s Paulson & Co, D E Shaw, and David Costen Haley’s HBK Investments. During the quarter, a total of 32 hedge funds out of the 730 we monitor had investments in the stock.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!